Equities Analysts Offer Predictions for TNGX FY2025 Earnings
Tango Therapeutics, Inc. (NASDAQ:TNGX – Free Report) – Cantor Fitzgerald dropped their FY2025 earnings per share (EPS) estimates for shares of Tango Therapeutics in a research report issued to clients and investors on Monday, March 10th. Cantor Fitzgerald analyst E. Schmidt now anticipates that the company will post earnings of ($1.48) per share for the […]
